As of Jun 23, 2026, the Zoetis stock's price-to-earnings ratio is 12.72. This results from the current EPS of $6.04 and stock price of $76.84. The PE ratio has decreased by 45% from the past four quarters average of 23.1.
The PE ratio of Zoetis has averaged 36.62 over the last ten years. The current P/E ratio of 12.72 is 65% lower than the historical average. In the past ten years, ZTS's PE ratio peaked in the Dec 2021 quarter at 56.88, when the stock price was $244.03 and the EPS was $4.29. The lowest point was in the Mar 2026 quarter, when it reached 19.57 with a price of $118.21 and an EPS of $6.04.
Maximum annual increase: 90% in 2015
Maximum annual decrease: -54.24% in 2016
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | 20.87 | -29.94% | $125.82 | $6.03 |
| 2024 | 29.79 | -23.32% | $162.93 | $5.47 |
| 2023 | 38.85 | 19.58% | $197.37 | $5.08 |
| 2022 | 32.49 | -42.88% | $146.55 | $4.51 |
| 2021 | 56.88 | 18.23% | $244.03 | $4.29 |
| 2020 | 48.11 | 14.14% | $165.5 | $3.44 |
| 2019 | 42.15 | 45.85% | $132.35 | $3.14 |
| 2018 | 28.9 | -29.39% | $85.54 | $2.96 |
| 2017 | 40.93 | 26.91% | $72.04 | $1.76 |
| 2016 | 32.25 | -54.24% | $53.53 | $1.66 |
| 2015 | 70.47 | 90% | $47.92 | $0.68 |
| 2014 | 37.09 | 14.58% | $43.03 | $1.16 |
| 2013 | 32.37 | N/A | $32.69 | $1.01 |
| 2012 | N/A | N/A | N/A | $0.87 |
| 2011 | N/A | N/A | N/A | $0.49 |
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2026 | 19.57 | -6.23% | $118.21 | $6.04 |
| Dec 2025 | 20.87 | -16.29% | $125.82 | $6.03 |
| Sep 2025 | 24.93 | -8.08% | $146.32 | $5.87 |
| Jun 2025 | 27.12 | -9.24% | $155.95 | $5.75 |
| Mar 2025 | 29.88 | 0.3% | $164.65 | $5.51 |
| Dec 2024 | 29.79 | -18.74% | $162.93 | $5.47 |
| Sep 2024 | 36.66 | 8.05% | $195.38 | $5.33 |
| Jun 2024 | 33.93 | 4.08% | $173.36 | $5.11 |
| Mar 2024 | 32.6 | -16.09% | $169.21 | $5.19 |
| Dec 2023 | 38.85 | 9.87% | $197.37 | $5.08 |
| Sep 2023 | 35.36 | -2.27% | $173.98 | $4.92 |
| Jun 2023 | 36.18 | -3.49% | $172.21 | $4.76 |
| Mar 2023 | 37.49 | 15.39% | $166.44 | $4.44 |
| Dec 2022 | 32.49 | -3.82% | $146.55 | $4.51 |
| Sep 2022 | 33.78 | -13.14% | $148.29 | $4.39 |
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
The current PE ratio of ZTS is lower than the 3, 5 and 10-year averages.
Zoetis's P/E of 12.72 is below the Healthcare sector, the industry and its peers average. In comparison with its Healthcare sector average of 23.78, Zoetis's P/E is 47% lower.
In comparison to its peer stocks LLY and MRK, ZTS's PE ratio is lower. Zoetis's PE ratio is trading below the peer group average of 26.17.
| Stock name | PE ratio | Market cap |
|---|---|---|
| ZTS Zoetis Inc | 12.72 | $32.21B |
| PAHC Phibro Animal Health Corp | 13.05 | $1.24B |
| PFE Pfizer Inc | 18.87 | $140.89B |
| MRK Merck & Co Inc | 33.5 | $295.39B |
| LLY ELI LILLY & Co | 39.27 | $1.04T |
| ICCC Immucell Corp | N/A | $89.25M |
ZTS stock has a price to earnings ratio of 12.72 as of Jun 23, 2026.
The 3-year average price to earnings ratio for ZTS stock is 30.48.
The 5-year average price to earnings ratio for ZTS stock is 35.07.
The highest quarterly PE ratio in the last ten years has been 56.88 and it was in the Dec 2021 quarter.
ZTS's price to earnings ratio is currently 65% below its 10-year historical average.
The P/E ratio is obtained by dividing the latest price of a stock by its trailing twelve months EPS. As of today (Jun 23, 2026), Zoetis's stock price is $76.84. The earnings per share for the trailing twelve months (TTM) ending Mar 2026 is $6.04. Therefore, Zoetis's PE ratio for today is 12.72. PE RATIO(12.72) = STOCK PRICE($76.84) / TTM EPS($6.04)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.